How would he “quickly make Elite succeed”, given the governmental/regulatory hurdles in pharma?
It takes months if not years to trial a potential ANDA, then several months to compile the data and file the ANDA, then 10+ months for approval IF no CRLs, then usually 2-3 more months to launch, and THEN you see the revenues start to build over the subsequent months and years.
These hurdles will always exist (unless laws/regulations change), regardless of who is CEO.